Outlook Business’ stock wizards put up a strong show in CY2014 with an average...
Shilpa Medicare
Daljeet Kohli’s experience with Ajanta Pharma and Shilpa Medicare shows that it is not...
Shilpa Medicare’s spectacular jump of 17% today is not an isolated instance. Most of...
Outlook Business deserves to be commended for persuading ten ace stock pickers to name...
Daljeet Kohli of IndiaNivesh has issued a comprehensive report previewing the Q3FY15 results of...
Daljeet Kohli has been on a winning streak in 2014. His winning stocks outnumber...
Niraj Dalal of 3A Capital Advisors and Manish Bhandari of Vallum Capital have indicated...
Shilpa Medicare’s relentless surge has caused Daljeet to sound a note of caution. He...
Last year, Motilal Oswal’s 18th Wealth Creation Study gave us five multi-bagger stocks on...
Daljeet Kohli has slashed the target price of Sharon Bio-Medicine from Rs. 140 to...